[go: up one dir, main page]

ES8300725A1 - "procedimiento para la preparacion de 3,1-benzoxazin-2-onas". - Google Patents

"procedimiento para la preparacion de 3,1-benzoxazin-2-onas".

Info

Publication number
ES8300725A1
ES8300725A1 ES508653A ES508653A ES8300725A1 ES 8300725 A1 ES8300725 A1 ES 8300725A1 ES 508653 A ES508653 A ES 508653A ES 508653 A ES508653 A ES 508653A ES 8300725 A1 ES8300725 A1 ES 8300725A1
Authority
ES
Spain
Prior art keywords
group
hydrogen
alkyl
methyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES508653A
Other languages
English (en)
Other versions
ES508653A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES8300725A1 publication Critical patent/ES8300725A1/es
Publication of ES508653A0 publication Critical patent/ES508653A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 3,1-BENZOXAZIN-2-ONAS Y DE SUS SALES DE ADICION DE ACIDOS, EN FORMA DE RACEMATOS, PARES DE ANTIPODAS DIASTEREOISOMEROS Y ENANTIOMEROS, DE FORMULA (I), EN LA QUE R Y R SON HIDROGENO O ALCOHILO C <003> ; R Y R SON HIDROGENO O METILO; R , R Y R PUEDEN SER VARIOS RADICALES Y N VALE DE 1 A 3. CONSISTE EN LA REACCION DE ALCOHILACION REDUCTIVA DE UN COMPUESTO DE FORMULA (II), CON UN COMPUESTO DE FORMULA (III), EN LAS QUE N Y R <024>R TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I); Y R, R , R Y R P PUEDEN SER VARIOS TIPOS DE RADICALES. LA REACCION SE LLEVA A CABO UTILIZANDO HIDRUROS COMPLEJOS O MEDIANTE HIDROGENACION CATALITICA EN DISOLVENTES ORGANICOS INERTES. >ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU EFECTO HIPOTENSOR Y TOCOLITICO Y COMO BRONCOLITICOS, VASODILATADORES Y AGENTES CARDIACOS.
ES508653A 1980-07-12 1982-01-12 "procedimiento para la preparacion de 3,1-benzoxazin-2-onas". Granted ES508653A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803026534 DE3026534A1 (de) 1980-07-12 1980-07-12 3,1-benzoxazin-2-one, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
ES8300725A1 true ES8300725A1 (es) 1982-11-01
ES508653A0 ES508653A0 (es) 1982-11-01

Family

ID=6107085

Family Applications (4)

Application Number Title Priority Date Filing Date
ES503837A Expired ES8205402A1 (es) 1980-07-12 1981-07-10 Procedimiento para la preparacion de 3,1-benzoxazin-2-onas
ES508655A Expired ES8300727A1 (es) 1980-07-12 1982-01-12 "procedimiento para la preparacion de 3,1-benzoxazin-2-onas".
ES508653A Granted ES508653A0 (es) 1980-07-12 1982-01-12 "procedimiento para la preparacion de 3,1-benzoxazin-2-onas".
ES508654A Granted ES508654A0 (es) 1980-07-12 1982-01-12 "procedimiento para la preparacion de 3,1-benzoxazin-2-onas".

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES503837A Expired ES8205402A1 (es) 1980-07-12 1981-07-10 Procedimiento para la preparacion de 3,1-benzoxazin-2-onas
ES508655A Expired ES8300727A1 (es) 1980-07-12 1982-01-12 "procedimiento para la preparacion de 3,1-benzoxazin-2-onas".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES508654A Granted ES508654A0 (es) 1980-07-12 1982-01-12 "procedimiento para la preparacion de 3,1-benzoxazin-2-onas".

Country Status (25)

Country Link
US (1) US4341778A (es)
EP (1) EP0043940B1 (es)
JP (1) JPS5748975A (es)
KR (1) KR850000755B1 (es)
AT (1) ATE9336T1 (es)
AU (1) AU540916B2 (es)
CA (1) CA1165317A (es)
DD (1) DD202018A5 (es)
DE (2) DE3026534A1 (es)
DK (1) DK149851C (es)
ES (4) ES8205402A1 (es)
FI (1) FI74703C (es)
GB (1) GB2080296B (es)
GR (1) GR74333B (es)
HK (1) HK98286A (es)
HU (1) HU183515B (es)
IE (1) IE52508B1 (es)
IL (1) IL63285A (es)
NO (1) NO158578C (es)
NZ (1) NZ197678A (es)
PH (1) PH17425A (es)
PT (1) PT73338B (es)
SG (1) SG77686G (es)
YU (1) YU170181A (es)
ZA (1) ZA814687B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446319A (en) * 1981-04-28 1984-05-01 Takeda Chemical Industries, Ltd. Aminocyclitols and their production
JPS62238288A (ja) * 1986-04-04 1987-10-19 Nippon Tokushu Noyaku Seizo Kk 環状カルバメ−ト及び農園芸用殺菌剤
FR2636065B1 (fr) * 1988-09-08 1993-05-07 Fabre Sa Pierre Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
FR2680172B1 (fr) * 1991-08-05 1993-11-19 Fabre Medicament Pierre Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
WO1996022775A1 (en) * 1995-01-24 1996-08-01 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5874430A (en) * 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
DE102004003428A1 (de) 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
JPWO2006077821A1 (ja) * 2005-01-19 2008-06-19 大日本住友製薬株式会社 アルドステロン受容体調節剤としての芳香族スルホン化合物
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
WO2008023001A1 (en) * 2006-08-22 2008-02-28 Boehringer Ingelheim International Gmbh Powder formulations for inhalation containing enantiomerically pure beta-agonists
UY30552A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
PE20080610A1 (es) * 2006-08-22 2008-07-15 Boehringer Ingelheim Int Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4163053A (en) * 1977-12-27 1979-07-31 Schering Corporation Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides
FI791727A7 (fi) * 1978-06-05 1981-01-01 Ciba Geigy Ag Menetelmä N-alkyloitujen aminoalkoholien valmistamiseksi.
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen

Also Published As

Publication number Publication date
NZ197678A (en) 1984-12-14
FI74703C (fi) 1988-03-10
FI812183L (fi) 1982-01-13
EP0043940A1 (de) 1982-01-20
HK98286A (en) 1986-12-24
KR850000755B1 (en) 1985-05-25
FI74703B (fi) 1987-11-30
DK149851C (da) 1987-05-04
ES508655A0 (es) 1982-11-01
ES8300727A1 (es) 1982-11-01
DK149851B (da) 1986-10-13
CA1165317A (en) 1984-04-10
ES8300726A1 (es) 1982-11-01
ZA814687B (en) 1983-03-30
AU7273181A (en) 1982-09-16
US4341778A (en) 1982-07-27
NO812355L (no) 1982-01-13
DD202018A5 (de) 1983-08-24
EP0043940B1 (de) 1984-09-12
SG77686G (en) 1987-02-27
GB2080296A (en) 1982-02-03
NO158578C (no) 1988-10-05
ES508653A0 (es) 1982-11-01
GR74333B (es) 1984-06-25
NO158578B (no) 1988-06-27
IE811567L (en) 1982-01-12
ATE9336T1 (de) 1984-09-15
ES503837A0 (es) 1982-06-01
ES508654A0 (es) 1982-11-01
DE3026534A1 (de) 1982-03-18
GB2080296B (en) 1983-09-28
IE52508B1 (en) 1987-11-25
PT73338A (de) 1981-08-01
PH17425A (en) 1984-08-08
JPS5748975A (en) 1982-03-20
DK306781A (da) 1982-01-13
DE3166003D1 (en) 1984-10-18
IL63285A (en) 1985-03-31
YU170181A (en) 1983-10-31
PT73338B (en) 1983-06-20
AU540916B2 (en) 1984-12-06
KR830006248A (ko) 1983-09-20
ES8205402A1 (es) 1982-06-01
HU183515B (en) 1984-05-28
IL63285A0 (en) 1981-10-30

Similar Documents

Publication Publication Date Title
ES8205402A1 (es) Procedimiento para la preparacion de 3,1-benzoxazin-2-onas
HUP9802694A1 (hu) Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
IL68093A0 (en) Theophyllinyl-alkyl-oxadiazoles,process for the preparation thereof and pharmaceutical compositions containing them
IL64647A (en) 2,8-disubstituted-4-thiomorpholino-pyrimido(5,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ES464013A1 (es) Procedimiento para preparar derivados sustituidos de orto- fenilendiamina.
ES8801637A1 (es) Un procedimiento para la preparacion de benzimidazoles.
GR3000488T3 (en) Novel 1,4-dihydropyridines containing fluorine, process for their preparation and their use as medicaments
ES8201575A1 (es) Procedimiento de obtencion de nuevos 2-aminoetanoles
ES8304936A1 (es) Procedimiento de preparacion de un nuevo derivado de benzoilfenil-piperidina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980921